zonisamide sold brand name zonegran among others medication used treat symptoms epilepsy parkinsons chemically sulfonamide serves anticonvulsant used primarily adjunctive therapy adults parkinsons disease partialonset seizures infantile spasm mixed seizure types syndrome myoclonic generalized tonic clonic despite also sometimes used monotherapy partialonset commonly prescribed medication united states million zonisamide approved united united adjunctive treatment partial seizures adults japan adjunctive monotherapy partial seizures simple complex secondarily generalized generalized tonic tonicclonic grand mal atypical absence combined australia marketed adjunctive therapy monotherapy partial seizures approved treatment motor symptoms parkinsons disease pd adjunct levodopa countries japan zonisamide used adjunct levodopa treatment since addition clinical evidence zonisamide combination levodopa control motor symptoms pd evidence treatment non motor symptoms pd adverse effects common incidence adverse effects include common incidence adverse effects include zonisamide carbonic anhydrase inhibitors topiramate furosemide hydrochlorothiazide known interfere amobarbital led inadequate anesthetization wada zonisamide may also interact carbonic anhydrase inhibitors increase potential metabolic additionally metabolism zonisamide inhibited ketoconazole ciclosporin miconazole fluconazole carbamazepine descending order inhibition due effects zonisamide known inhibit cytochrome enzymes present therapeutic zonisamide antiseizure drug chemically classified sulfonamide unrelated antiseizure agents precise mechanism zonisamide exerts antiseizure effect unknown although believed drug blocks sodium ttype calcium channels leads suppression neuronal hypersynchronization seizureform also known weak carbonic anhydrase inhibitor similarly anticonvulsant topiramate also known modulate gabaergic glutamatergic variable yet relatively rapid rate absorption time peak concentration hours bioavailability close food effect bioavailability zonisamide may affect rate zonisamide metabolized mostly isoenzyme also via reductive cleavage zonisamide discovered uno colleagues launched dainippon sumitomo pharma formerly dainippon pharmaceutical excegran marketed élan united states starting zonegran élan transferred interests zonisamide eisai co ltd eisai also markets zonegran asia china taiwan fourteen europe starting germany united openlabel trial zonisamide attenuated symptoms tardive also studied significant positive effects body weight loss three ongoing clinical trials sold combined bupropion brand name empatic development zonisamide studied used migraine preventative medication topiramate either ineffective continued due side also used offlabel psychiatrists mood stabilizer treat bipolar httpsenwikipediaorgwikizonisamide